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SUMMARY
Peptide sequencing by computational assignment of tandem mass spectra to a database of putative protein sequences provides an independent approach to confirming or refuting protein predictions based on large-scale DNA and RNA sequencing efforts. This use of mass spectrometrically-derived sequence data for testing and refining predicted gene models has been termed proteogenomics. We report herein the application of proteogenomic methodology to a database of 10.9 million tandem mass spectra collected over a period of two years from proteolytically generated peptides isolated from the model legume Medicago truncatula. These spectra were searched against a database of predicted M. truncatula protein sequences generated from public databases, in silico gene model predictions, and a whole-genome sixframe translation. This search identified 78,647 distinct peptide sequences, and a comparison with the publicly available proteome from the recently published M. truncatula genome supported translation of 9,843 existing gene models and identified 1,568 novel peptides suggesting corrections or additions to the current annotations. Each supporting and novel peptide was independently validated using mRNAderived deep sequencing coverage and an overall correlation of 93% between the two data types was observed. We have additionally highlighted examples of several aspects of structural annotation for which tandem MS provides unique evidence not easily obtainable through typical DNA or RNA sequencing.
Proteogenomic analysis is a valuable and unique source of information for the structural annotation of genomes and should be included in such efforts to ensure that the genome models utilized by biologists mirror as accurately as possible what is present in the cell.
INTRODUCTION
Many analyses in systems biology rely on an annotated genomic sequence as a starting point, and the quality of the genome sequence and annotation directly affects the reliability of the resulting conclusions. Improving the accuracy of the structural and functional annotation should therefore be a major focus in the study of any model organism, and many sources of data are available which can be used to assist in this effort. Common sources of experimental evidence used to improve in silico gene model predictions include the sequences of full-length cDNA clones and expressed sequence tag (EST) libraries, alignment of homologous sequences from related organisms, and, more recently, the deep sequencing of mRNA-derived cDNA libraries using next-generation platforms (RNA-Seq). The use of information from these sources can significantly improve the results of automated gene-calling efforts, but all operate at the transcript level and are unable to differentiate between coding and non-coding sequences. The field of proteogenomics has recently emerged in response to this perceived gap. Broadly defined, proteogenomics is the use of proteomics data and methodology to assist in the annotation of genome sequences. This typically involves the "sequencing" of an organism's proteome using tandem mass spectrometry (MS/MS) with a greatly expanded search database consisting of published protein sequences, possible splice variants, and a six-frame translation of the entire genome. The identified peptide sequences are then mapped back to the genome, and these peptide/genome mappings are used to confirm, refute, or add to existing gene annotations. They can also be included directly in the annotation pipeline alongside other sources of evidence. Proteogenomics, along with other recent developments such as ribosome profiling (1, 2) , can thus provide an additional layer of information to assist in delineating transcript coding regions and reading frames.
Recently the draft sequence of the Medicago truncatula genome was released (3). M. truncatula, a relative of the important agricultural crop alfalfa, serves as a model organism for the legume family and is the focus of much research to understand the mechanisms of symbiosis between the plant and soil microbes which result in fixation of atmospheric nitrogen. Although publication of the draft sequence is an important step forward for Medicago researchers, efforts to improve the genomic assembly and structural and functional annotations are ongoing. In order to assess the quality of the published annotations and establish an independent source for improving them, we have evaluated the use of existing MS/MS data to confirm or correct current gene models and discover possible novel, unannotated genes in the M. truncatula genome. Similar work carried out in other sequenced organisms (4-9) has shown the potential for this type of analysis, and proteogenomic data for the model organism Arabidopsis is being incorporated directly into the structural annotation process (10) . MS/MS data can confirm expression of current gene models, help to correct errors in splice sites and reading frames, suggest missing exons and alternative splicing, and provide evidence for novel genes missing from the current annotations. We utilized a database of 10.9 million MS/MS spectra generated from ongoing proteomic and phosphoproteomic studies to test the utility of this approach in the model legume. While the vast majority of identified peptides supported existing gene models, there is evidence for the need for further work to improve the Medicago annotations. Conclusions based on mapped peptide evidence were independently validated using a database of 341 million RNA-Seq reads taken from ongoing transcriptomics experiments. The results demonstrate the validity of the use of MS/MS data to improve the quality of existing structural annotations, particularly in cases in which peptide data provides evidence not derivable from other sources. In practice, all available sources of information (MS/MS, RNA-Seq, EST databases, etc) should be used simultaneously to guide the construction of accurate gene models both by automated gene calling and, where feasible, by manual curation.
EXPERIMENTAL PROCEDURES

Sample preparation and MS/MS
The data used in this study were generated from tissue of M. truncatula 'Jemalong A17' wildtype as well as C31 and TRV25 mutants in 11 different experiments using multiple growth conditions, treatments and protein isolation procedures. Aeroponic and hydroponic plants were grown as described previously (11, 12) . Additionally, seedlings were sown on 23 x 23 cm 2 plates containing modified Fahraeus medium overlaid with moist sterile germination paper and grown at room temperature in the dark for five days. All plants were treated for one hour by replacement of the medium with modified Fahraeus medium with and without 10 -8 M Nod factors obtained from Sinorhizobium meliloti strain Rm1021 pRmE43 (pTE3:nodD1) as described in (12) . Seedlings were harvested after one hour of treatment and either flash frozen in liquid nitrogen or processed using two-phase isolation of membrane fractions as outlined in (13) .
Proteins were isolated for MS/MS analysis from whole-cell lysates of flash-frozen root tissue or membrane-enriched fractions with the addition of a variety of phosphatase inhibitors as described previously (37) . Protein samples were reduced with DTT at a final concentration of 5 mM and alkylated with 15 mM iodoacetamide before final capping with 5 mM DTT. Proteins were digested with trypsin, derivitized with isobaric labels (TMT 6-plex, iTRAQ 4-plex, or iTRAQ 8-plex according to experiment) (14, 15) and fractionated by strong cation exchange (SCX). For phosphorylation experiments, samples were enriched for the presence of a phosphate group by IMAC chromatography. All samples were analyzed on a LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). For mRNA sequencing, seedlings from 'Jemalong A17' wildtype grown using the plate system were used and root tissue was excised and flash frozen. RNA was isolated using a Qiagen RNeasy Plant Mini kit. Sequencing libraries were prepared using the Illumina TruSeq RNA Sample Preparation Kit (mRNA protocol rev. A) and sequenced on an Illumina HiSeq 2000 system.
Database generation, searching, and false discovery rate estimation
The database of protein sequences used for spectral searching was generated from several The three sets of predicted protein sequences were reduced to a non-redundant database using in-house software to remove duplicate protein entries. Redundant proteins were determined by comparing amino acid sequences (ignoring I/L ambiguity) for an exact match against all other proteins. A decoy database of reversed sequences was added for the purpose of false discovery rate (FDR) estimation as described previously (17) .
Database searching was performed using the Coon OMSSA Proteomic Analysis Software Suite (COMPASS) (18) and utilizing the Open Mass Spectrometry Search Algorithm (OMSSA) version 2.1.8 (19) . Proteins were digested in silico by OMSSA using tryptic cleavage specificity. Peptide precursors were searched using a multi-isotopic search (±50 ppm, max 4 isotopes) and product ion mass tolerance was set to ±0.015 Da. Carbamidomethylation of cysteines, isobaric labeling (TMT or iTRAQ) on the Nterminus, and isobaric labeling on lysines were included as fixed modifications. Oxidation of methionines and isobaric labeling on tyrosines were included as variable modifications. For all phosphorylation experiments, variable modifications of phosphorylation on threonines, serines and tyrosines were applied.
Results were filtered to a 1% peptide FDR based on decoy database matches using the high resolution tool FDROptimizer from the COMPASS suite. Peptides were further grouped into protein groups and filtered to a 1% protein FDR based on the product of included peptide p-values. The highest (worst) pvalue was used when peptides were observed in multiple spectra. Only peptides belonging to filtered protein groups were used in further analysis.
Peptide mapping and analysis
The full list of spectral matches was collapsed to a set of unique peptide sequences. Each peptide was mapped back to its genomic location(s) using a combination of database/peptide and database/genome coordinate tables, taking into account split peptides spanning splice junctions and Leu/Ile ambiguity. This generated a set of expressed peptide tags (EPTs) as originally defined by Savidor et al (6) . Each EPT was subsequently classified by a number of non-exclusive criteria using a combination of the bedtools software package (20) , in-house scripts, and manual inspection using the Integrative Genomics Viewer (IGV) (21) . Intergenic clusters were generated by single-linkage clustering using bedtools with a distance cutoff of 1500 bp. AUGUSTUS was used to search for alternative gene models for intragenic nEPT loci and for novel gene models at intergenic nEPT clusters, allowing for multiple alternative transcripts per model with a sampling of 100 and using EPT-based hints to guide prediction.
RNA-Seq Validation
A total of 340,622,166 100bp single-end reads from Illumina HiSeq2000 sequencing of M.
truncatula 'Jemalong A17' poly-A enriched mRNA were mapped to the Mt3.5 genome using Tophat v1.3.2 (22) . Parameters for minimum intron size, maximum intron size, and microexon searching were set to 10, 20000, and TRUE, respectively. All other parameters used default settings. A total of 269,109,482 reads were successful mapped to the genome. These alignments were used in both automated validation using bedtools and in-house software as well as visual validation using IGV.
RESULTS
Spectral searching against our M. truncatula protein databases resulted in 1.7 million spectral matches at a 1% protein FDR (Supplemental Table 1 ), representing 78,647 unique peptide sequences. Of these, 78,558 unique peptide sequences were mapped to 112,720 locations on the genome with no mismatches allowed. We refer to these unique peptide sequences as expressed peptide tags or EPTs, as suggested by Savidor et al. (6) . The parallel to the terminology of ESTs emphasizes that, for the purposes of proteogenomics, EPTs occupy genome coordinate space. Of these EPTs, 62,802 mapped to unique locations, 10,608 mapped to two locations and 5,148 mapped to three or more locations. The median length of identified EPT sequences was 14 a.a, with a minimum length of 5 a.a. and a maximum of 89 a.a. (Fig. 1a) . While the overwhelming majority of peptides mapped to only one location, a comparison of length against mapping count for each EPT showed distinct non-specificity for short peptides (Fig. 1b,c) .
The median mapping count for 5 a.a. EPTs is 62 locations, with no 5 a.a. EPT mapping to fewer than 40 locations. The median mapping count for 6 a.a. EPTs is 6, while at a length of 7 a.a the median falls to one. Based on this analysis, and in order to minimize the number of spurious mappings resulting from the probability of any given short peptide occurring randomly in a six-frame translation of the genome, we discarded from consideration any EPTs shorter than 7 a.a. This reduced the number of unique EPTs by 0.2% to 78,362 while reducing the number of mapped locations by 6.0% to 105,973 (Table 1) . A similar threshold has been used by others in proteogenomic studies (23) . EPTs above this threshold were further classified and characterized as described in the following sections and are summarized in Table 1 .
Supporting peptides
The Mt3.5v4 release of the M. truncatula gene models contains 64,152 predicted protein-coding models, although many of the models located in short-read sequencing scaffolds are expected to be partial fragments of the same genes due to the relatively small size of the assembled contigs (Illumina N50 = 2364; N80 = 1095). A total of 76,505 EPTs were mapped to 95,633 locations that were in agreement with the published gene models of Mt3.5v4. These supporting EPTs (sEPTs) provide evidence for translation of the existing gene models. Of the 64,152 current Mt3.5v4 gene models, 160 were covered by sEPTs over > 80% of their coding sequence length, 2205 had > 50% sEPT coverage, and 15,541 contained at least one sEPT as evidence of translation (Table 2) . A more stringent evaluation considering only gene models containing two or more sEPTs with at least one uniquely mapped at that genomic locus provides evidence for the translation of 9,843 gene models (Supplemental Table 2 ).
N-terminal modification
In order to take advantage of the unique nature of MS/MS data as applied to structural annotation, we analyzed the sEPT data set to look for evidence of N-terminal methionine excision (NME). A total of 352 sEPTs were identified as being N-terminal (starting at position 1 or 2 of the protein sequence).
Thirty-eight of these were filtered out as being contained within longer peptides in the full set of EPTs, suggesting possible degradation. Of the remaining sEPTs, 47 mapped to position +1 of the protein sequence and 267 mapped to position +2 (evidence of N-terminal methionine excision). This suggests a cleavage rate of 85%, in agreement with research in other organisms finding that the majority of both cytoplasmic and organellar proteins undergo NME in plants as well as other eukaryotes and prokaryotes (24) (25) (26) (27) . The frequency of occurrence of each of the 19 possible amino acids (Leu and Ile are indistinguishable in MS/MS) was determined at the +1 position in cleaved and +2 position in uncleaved N-terminal sEPTs (Fig. 2) . The activity of the MAP peptidases involved in NME is thought to be specific to small second position amino acids, typically one of [GAPCSTV] (24, 25, 28) . Our results show a high MAP specificity for [GAPTV] in the +2 position, all of which result in > 93% cleavage frequency. Serine showed a slightly lower frequency of cleavage, and cysteine was never observed at the +1 position in any of the identified N-terminal sEPTs. It should be noted that another common post-translation modification, N-alpha-acetylation (NAA), has also recently been shown to occur in a large portion of the proteome of Arabidopsis (27) . We did not specifically search for acetylation modifications, so it is possible that the ratio of cleaved to non-cleaved termini could be affected by the lack of acetylated identifications if acetylation occurs more or less frequently in cleaved vs non-cleaved proteins.
Intragenic novel peptides
The remainder of the analysis dealt with so-called "novel" EPTs (nEPTs) -peptides which could not be explained by any existing gene models. Of the 1,568 novel peptides identified, 552 were intragenic (i.e. overlapped existing gene models, including introns and UTRs) at 597 locations in the genome. These were classified according to a number of criteria in order to roughly quantify the types of evidence they provide. A total of 79 spliced nEPTs were identified which suggested novel splice junctions at 75 genomic locations. A visual inspection of these locations indicated that 64 were supported by RNA-Seq alignments as being the only or predominant splice form, suggesting corrections to the gene models.
These were classified as corrections to donor sites (n=14), acceptor sites (n=15), both donor and acceptor sites (n=4), extraneous exons/introns (n=19), missing exons/introns (n=11), and incorrectly split genes (n=1). Seven sites were covered by EPTs with both annotated and novel splice forms, giving strong evidence for alternative splicing at these locations. Five of these nEPTs were the minor form based on spectral match counts and two were major forms. One additional nEPT was suggested to be a minor splice form by RNA-Seq alignments alone, and three novel splice sites were unsupported by RNA-Seq data. Overall, of the 75 novel splice junctions, 71 (95%) were supported by 10 or more (median = 500) spliced mRNA reads with identical donor and acceptor sites, indicating a high degree of correlation between EPT and RNA-Seq evidence for splice site correction.
The 504 unspliced intragenic nEPT locations were classified as either completely within exons (33%), completely within introns (20%), or overlapping exon boundaries (47%). These locations were further examined by visual inspection alongside RNA-Seq alignments to assign putative explanatory categories (Table 3) . A total of 201 locations suggested splice corrections. Of these, 86 suggested removal of extra introns at the 3' end, one of the more consistent patterns observed in the nEPT data.
Frameshifts resulting from small insertions or deletions (indels) in the genomic sequence which are clearly visible in the RNA-Seq alignments accounted for another 56 intragenic nEPT locations. These 1-2 bp indels generally resulted in either a truncation of the gene model or the insertion of an erroneous intron to correct for the frameshift (Fig. 3) . While nEPT data itself cannot confirm the presence of these errors, it can provide strong supporting evidence for possible mistakes identified using more direct evidence such as DNA or RNA sequencing. An additional 99 nEPT locations overlapping the ends of gene models located near the ends of short genomic contigs are assumed to be due to the incomplete nature of the gene models and would likely be resolved with an improved genome assembly. The remainder of the unspliced intragenic nEPTs were classified into a number of smaller categories, including alternate ATG usage, strand/frame disagreements, gene fusion corrections, and possible noncanonical start codon usage as described below.
Gene model refinement based on intragenic nEPTs
AUGUSTUS was used to search for refined gene models for each intragenic nEPT locus. A region of 10,000 bp on either side of each intragenic nEPT was defined, and overlapping regions were merged using bedtools. Each region was searched using AUGUSTUS for all predicted transcript variants.
Each intragenic nEPT was re-mapped to the resulting protein sequences and classified as either explained by or not explained by these predicted models, and a minimal set of predicted gene models explaining all possible nEPTs was generated. Of the 552 intragenic nEPT locations initially identified, 390 were explained by a minimal set of 293 refined gene models.
Non-canonical translation initiation
The recurring identification of nEPTs with no upstream in-frame canonical (ATG) start codons led us to investigate the possibility of non-canonical start codon usage in M. truncatula. Non-canonical start codon usage, or the use of a codon other than ATG for translation initiation, is not uncommon in prokaryotes, occurring in approximately 17% of Escherichia coli genes (29) . Evidence for non-canonical usage has also been found in eukaryotic organisms for a small number of genes (30) (31) (32) (33) (34) (35) , and in silico homology-based analysis can be used to identify further potential candidates (36) . The emerging technique of ribosome profiling has provided further evidence that the phenomenon may be more common in eukaryotes than previously thought (1,2). Non-canonical start codons in other eukaryotic organisms tend to have a single base difference from the canonical ATG codon, as well as having optimal or near-optimal surrounding sequence context. For example, in plants there is an increased frequency of A or G at the -3 position and G at the +4 position (34) . Analysis of the surrounding sequence context of annotated translation start sites in M. truncatula shows a similar trend (Fig 4) . This information allows for a qualitative analysis of the likelihood of a given non-canonical codon being used for translation initiation when EPT evidence suggests such an event.
After removing from consideration loci with clear RNA-Seq evidence for missing 5' exons, as well as loci within 5000 bp of the 5' end of a contig (which may also have missing 5' exons) and loci without any supporting RNA-Seq evidence, we evaluated 7 loci for the potential use of non-canonical start codons. To be considered as a possible start site, a codon must have both optimal nucleic acid residues at positions -3 and +4 and have no more than a one base difference from the canonical ATG codon. Of the 7 loci considered, 5 contained upstream in-frame codons satisfying these criteria.
Highlighted in Figs. 5 and 6 are two examples with particularly strong supporting evidence based on homology to other published work. As the N-termini of proteins often direct cellular localization, it is important that gene models contain accurate coding sequence boundaries, and proteogenomics is one of only a handful of tools able to provide evidence for possible mistakes in start codon annotation. It should be noted, however, that due to the low expected frequency of noncanonical usage events compared to the inherent 1% error rate in peptide assignments, evaluation of such EPT evidence is of more use in manual curation than in automated gene calling pipelines and would require additional supporting evidence such as provided for the two examples given.
Intergenic novel peptides
The remaining 1,060 novel EPTs mapped to 1,134 intergenic locations on the Mt3.5 genome. For our purposes, "intergenic" is defined as having no overlap with existing gene models, including annotated UTRs. These nEPTs generally fall into two categories -evidence for novel gene models and evidence for the extension of existing gene models. Initial classification was done by single-linkage clustering, both to other novel EPTs and to existing gene models. Choosing an appropriate distance for clustering is complicated in eukaryotic organisms where exons from a single gene can be separated by large distances.
An increase in distance results in an increased likelihood of EPTs from adjacent genes being clustered together, while a decrease in the distance cutoff results in an increased likelihood of single-gene EPTs being clustered separately. In practice, the impact of the first type of error is minimized during the gene modeling stage. EPTs incorrectly clustered together are filtered out when predicted models are tested for inclusion of all clustered peptides. On the other hand, the second type of error may result in missed novel genes, as a gene containing two novel EPTs that are incorrectly clustered separately would not pass the minimum EPT count filtering. We therefore chose a distance cutoff of 1500 bp, which represents the 96 th percentile of the intron length distribution and the 36 th percentile of the intergenic distance distribution in Mt3.5v4, in order to minimize the second error type. Using this distance, nEPTs clustering with existing models were considered as likely evidence of gene model extensions, and the remaining clusters were considered as likely evidence of novel unannotated genes.
The 993 intergenic nEPT locations clustered into 209 novel clusters of two or more peptides and 118 clusters with existing genes, with 227 nEPTs remaining as singletons. Clusters containing existing gene models were considered to be evidence for extension of the current models. Novel clusters were further filtered to remove those not containing at least one uniquely mapped peptide, leaving 201 clusters considered as possible evidence for novel genes. Each cluster, along with 10,000 bp of genomic sequence on either side, was analyzed with the AUGUSTUS gene finding software to look for predicted gene models. For 190 of the novel clusters, gene models were predicted which contained all of the clustered peptides. Gene models were predicted for an additional 2 clusters which contained at least 1 unique and 2 total peptides but did not contain all clustered peptides, possibly due to incorrect clustering. The translation products of these novel genes were searched against the RefSeq protein database using NCBI BLAST (37) with an e-value cutoff of 1e -20 , and a list of the top hit and relevant scores for each of the 133 clusters with RefSeq hits can be found in Supplemental Table 3 .
Most novel clusters (92%) were found in short read contigs, suggesting a strong possibility that they are only partial models. In order to determine probable full-length models, we used two additional filtering criteria. AUGUSTUS was set to allow partial gene models at the ends of genomic sequences, and only 70 of the 192 gene models it built contained both annotated start and stop codons. These were further filtered during the BLAST search by comparing the length of the predicted protein to that of the best RefSeq hit. Predicted proteins which were at least 80% of the length of the best hit and which aligned to the best hit starting within 20 a.a. of the N-terminus were classified as being likely to be full-length models. This is a rather simplistic approach and relies on the robustness of the RefSeq database to deduce the expected length of the protein, but it gives an initial estimation of the quality of the predicted novel genes. The 34 cluster models passing this filtering are listed in Table 4 , along with the total number of nEPTs in the cluster, the number of uniquely mapping nEPTs, and the description, percent identity, and E-value of the best RefSeq hit for each associated gene model.
Full validation using RNA-Seq alignments
In order to evaluate the overall validity of the EPT mapping, the minimum read coverage over the length of the mapped tag for both supporting and novel EPTs was calculated using a set of 269 million 100 bp Illumina reads generated from M. truncatula 'Jemalong A17' mRNA and mapped to the Mt3. It is sometimes assumed that peptides with higher spectral match counts (peptide spectral matches -PSMs) are more reliable. For our purposes, a PSM is defined as an independent observation of a given spectrum/peptide match and the PSM count is the number of individual spectra matching a given peptide sequence. To test this hypothesis, we repeated the above analysis on sEPTs grouped by PSM and calculated the percent of sEPTs confirmed at each PSM level. Fig. 7 shows a plot of spectral match count against percent RNA-Seq correlation for PSMs in the range of 1-150. The slope of the linear model fitted to this plot is near zero, suggesting little or no correlation between spectral count and the reliability of peptide identification as evidenced by RNA-Seq correlation.
Data availability
All raw spectra and relevant analysis files are available at the Medicago Omics Repository (http://more.biotech.wisc.edu).
DISCUSSION
Proteogenomics is a valuable tool for enhancing existing structural annotations of sequenced organisms. We have endeavored to apply this technique to the model legume Medicago truncatula in order to gain a further understanding of the state of the published genome and annotations. The purpose of this effort was primarily exploratory in nature. In practice, expressed peptide tag data should be incorporated directly into gene model prediction software alongside other forms of evidence such EST, RNA-Seq, and homologous protein data. Some existing gene modeling tools, such as AUGUSTUS and Maker, already have this capability. EPT data can also be used for manual curation of individual genes, either by research groups for their gene(s) of interest or in the course of systematic manual curation for a full genome. Both types of analysis are facilitated by the aggregation of MS/MS data by genome working groups who can process it and provide it to end users as EPTs either by download or within genome browsers such as GBrowse and IGV. We are providing our full set of existing EPT data to the International Medicago Genome Annotation Group to assist in their efforts and envision similar collaborations in the future as more MS/MS data is generated.
While MS/MS and EPT data can serve a unique role in any genome annotation effort, some aspects of structural annotation are just as easily and in some cases more reliably deduced based on other types of evidence. This includes the correct identification of splice sites during mRNA processing, which are a source of common errors in structural annotations based on computer prediction. We have demonstrated the ability of proteogenomics to locate such errors, but also shown a high correlation between EPT evidence and that provided by RNA-Seq alignments. Due to this overlap, and the typically higher level of coverage across any given transcriptome that RNA-Seq provides compared to MS/MS, some researchers in the genomics community have questioned the usefulness of proteogenomic analyses.
However, our analysis has demonstrated the reliability of EPT data as an additional tool for genomic work. We have shown that novel peptides are supported by RNA-Seq alignments at only slightly lower levels than supporting peptides, and peptides with low spectral match counts do not appear to be less reliable than those with higher counts based on the same RNA-Seq correlation. We conclude, therefore, that when such data is generated in the course of other experiments it can and should be utilized as an additional source of information for genome annotation. EPT data can play a role in supporting other evidence and increase the confidence level of a gene model. Its most useful role, however, is in providing evidence that cannot be readily deduced from other common sources of data. This includes confirming translation of questionable coding sequence (such as short ORFs or annotated pseudogenes), correcting reading frames for gene models with several viable alternatives, distinguishing precursor mRNA from retained introns in RNA-Seq and EST sequencing evidence, and providing evidence for rare but potentially important events such as non-canonical start codon usage. Along with other recent developments such as ribosome profiling, it can provide structural information at the coding sequence and even codon level, and can also provide clues to the prevalence of post-translational modifications such as N-terminal methionine excision, provided the spectral search methods used allow for such detection.
Of the 78,362 filtered unique peptides identified in this study, only 1,568 (2.0%) were novel. This contrasts with the 12.5% of 144,079 peptides identified as novel in a similar study in Arabidopsis (4).
Assuming that we are using similar definitions of identified and novel peptides, the significantly lower proportion of novel peptides identified in M. truncatula is surprising. The Arabidopsis genome sequence and annotations are typically considered to be of high quality, while the Medicago draft sequence was only recently published and annotation efforts are still in the early stages. It is possible that the increased number of novel peptides observed in the Arabidopsis study is a consequence of the larger spectral library genome sequence if possible. After filtering out peptides < 7 aa in length, the remaining EPTs were classified into initial categories as shown. Unique EPT counts represent unique sequences, while location counts represent unique loci on the genome to which EPTs map. Intragenic EPTs are considered to be those which have any overlap with current gene models, including coding sequences, introns, and untranslated regions. Table 2 . Summary of supporting evidence for existing gene models. For each annotated gene model, the fraction of transcript length covered by at least one EPT at each base position was calculated using bedtools. R (38) was used to transform the resulting coverage counts into a cumulative frequency table.
Fractions listed represent the lower edge of bins, exclusive. The total number of predicted gene models is likely to be artificially high due to splitting of genes over multiple small short read contigs. Table 3 . Classification of unspliced intragenic nEPTs. Each nEPT location was classified by visual inspection of mapped EPT on the genome alongside the published gene models, six reading frame translations, and RNA-Seq read alignments using IGV. EPTs were grouped into common categories based on the most likely type of addition or correction suggested. Logo was generated using WebLogo 3.2 (39) from a TRANSFAC motif file generated in-house. 
